BENJAMIN A GROSS
Medical Practice in Philadelphia, PA
License number
Pennsylvania MD002382E
Category
Medicine
Type
Medical Physician and Surgeon
Address
Address
Philadelphia, PA 19111
Personal information
See more information about BENJAMIN A GROSS at radaris.comName
Address
Phone
510 Delancey St, Philadelphia, PA 19106
501 Plush Mill Rd APT 413, Wallingford, PA 19086
1017 Walsh Ln #158, Narberth, PA 19072
1111 W Old Wynnewood Rd, Wynnewood, PA 19096
211 Costello Rd, Austin, PA 16720
Professional information
Director, Business Development At Sodexo (Former Sodexho)
Position:
Director, Business Development at SODEXO (former SODEXHO)
Location:
Greater Philadelphia Area
Industry:
Facilities Services
Work:
SODEXO (former SODEXHO)
since Oct 2008
-
Director, Business Development
Professional Services
2005 - 2008
-
Sales Director
Education:
New York University 1972 - 1974
MPA, Health Care Policy and Administration New York University - Leonard N. Stern School of Business 1968 - 1972
MPA, Health Care Policy and Administration New York University - Leonard N. Stern School of Business 1968 - 1972
Skills:
Facilities Management, Contract Negotiation, New Business Development, Management, Outsourcing, Operations Management, Contract Management, Strategic Planning, Budgets, Strategy, Healthcare, Sales, Income Statement, Business Strategy, Business Development, Leadership, Process Improvement, Change Management, Customer Satisfaction, Project Planning
Methods And Compositions For Detections And Modulating O-Glycosylation
US Patent:
8524444, Sep 3, 2013
Filed:
Jun 13, 2008
Appl. No.:
12/664559
Inventors:
Benjamin Gross - Philadelphia PA, US
Suzanne Walker Kahne - Brookline MA, US
Jonathan G. Swoboda - Oil City PA, US
Suzanne Walker Kahne - Brookline MA, US
Jonathan G. Swoboda - Oil City PA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
C12Q 1/00
US Classification:
435 4, 435 15, 435 23
Abstract:
The invention relates to methods and products for modulating glycosylation of proteins. The invention is useful for identifying therapeutic compounds to treat glycosylation-associated disorders such as neurodegeneration, diabetes, including complications of diabetes such as insulin resistance, nephropathy, microvascular damage, and endothelial dysfunction. The invention is also useful for identifying therapeutic compounds to treat de-glycosylation-associated disorders such as ischemic damage and traumatic injury. The invention also relates in part to assays that are useful for identifying and testing candidate compounds for modulating glycosylation of proteins and also relates in part to compounds to treat glycosylation-associated diseases and disorders.
O-Glcnac Transferase Inhibitors And Uses Thereof
US Patent:
2012010, May 3, 2012
Filed:
Jun 1, 2010
Appl. No.:
13/375036
Inventors:
Suzanne Walker Kahne - Brookline MA, US
Michael Block Lazarus - W. Newton MA, US
Benjamin J. Gross - Philadelphia PA, US
Michael Block Lazarus - W. Newton MA, US
Benjamin J. Gross - Philadelphia PA, US
Assignee:
President and Fellows of Harvard College - Cambridge MA
International Classification:
A61K 31/496, C07D 401/12, C07D 409/14, C07D 215/36, C07D 417/12, C07D 405/14, C07D 405/12, A61K 31/4709, A61K 31/4725, C12N 5/071, A61P 25/00, A61P 35/00, A61P 3/10, A61P 29/00, A61P 37/00, C07D 401/14
US Classification:
51425307, 544363, 546158, 546157, 546141, 546143, 514312, 514310, 435375
Abstract:
The present invention provides inhibitors of O-GIcNAc transferase. Typically, the inhibitors are quinolinone-6-sulfonamides. The invention also provides pharmaceutical compositions thereof and methods for using the same in diabetes and complications thereof, neurodegenerative diseases, cancers, autoimmune diseases, and inflammatory diseases.